Immunology and Infectious Disease researchers working in the Department of Veterinary and Biomedical Sciences at Penn State.

  • Distinguished Professor of Molecular Immunology

Areas of Expertise

  • Host resistance to infection
  • Immune-mediated diseases: multiple sclerosis, and inflammatory bowel disease
  • T cells
  • Gastrointestinal microbiota; Gnotobiotics
  • Vitamins A & D regulation of immune function
  • Edible mushrooms
  • Selenium
  • Professor of Molecular Toxicology and Carcinogenesis
  • Associate Chair, Molecular Cellular and Integrative Biosciences Graduate Program
  • Professor of Public Health
  • Bacteriology Section Head, PADLS-Penn State Animal Diagnostic Laboratory

Areas of Expertise

  • Diagnostic Microbiology
  • Veterinary Public Health
  • Food Safety
  • Epidemiology
  • New and Emerging Infectious Diseases
  • Associate Professor

Areas of Expertise

  • Immunologic mechanisms of Bordetella
  • Pathogenesis of Francisella tularensis
  • Host-pathogen interactions
  • Development of BSL-3 research programs
  • Professor of Veterinary and Biomedical Sciences

Areas of Expertise

  • Hematology
  • Erythropoiesis
  • Anemia Research
  • Leukemia
  • Department Head
  • Professor of Immunology and Molecular Toxicology

Areas of Expertise

  • Redox biology with an emphasis on selenium and selenoproteins
  • Macrophage biology- emphasis on inflammation and resolution
  • Endogenous bioactive lipid mediators
  • Cancer (leukemia) and leukemia stem cells
  • Redox control of stress erythropoiesis during inflammation
  • Professor of Molecular Virology
  • Director, Pathobiology Graduate Program

Areas of Expertise

  • Virology
  • Infectious Disease
  • Viral Budding
  • Cellular Trafficking
  • Virus-like Particles
  • Zoonoses
  • Assistant Professor of Veterinary and Biomedical Sciences

Areas of Expertise

  • Animal models of influenza
  • Airborne transmission of influenza viruses
  • Evolution of pandemic influenza viruses
  • Highly pathogenic avian influenza
  • Development of live-attenuated influenza vaccine platforms
  • High containment BSL3+ research